2018 annual financial data
Keros Therapeutics 2018 Operating margin
Keros Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was -16.91%.
Operating income was -1,691,000 USD and net income was -1,335,000 USD.
Operating cash flow was 7,042,000 USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,000,000 USD
- Operating income
- -1,691,000 USD
- Net income
- -1,335,000 USD
- Operating cash flow
- 7,042,000 USD